173 related items for PubMed ID: 15378419
1. Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?
Davin JC, Merkus MP.
Pediatr Nephrol; 2005 Jan; 20(1):10-4. PubMed ID: 15378419
[Abstract] [Full Text] [Related]
2. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC, all members of the Levamisole Study Group.
Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
[Abstract] [Full Text] [Related]
3. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM.
BMJ Open; 2019 Aug 01; 9(8):e027011. PubMed ID: 31375606
[Abstract] [Full Text] [Related]
4. Levamisole treatment in steroid sensitive nephrotic syndrome.
Alshaya HO, Kari JA.
Saudi Med J; 2002 Sep 01; 23(9):1101-4. PubMed ID: 12370722
[Abstract] [Full Text] [Related]
5. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
[Abstract] [Full Text] [Related]
6. Effect of levamisole in steroid-dependent nephrotic syndrome.
Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
Iran J Kidney Dis; 2010 Oct 27; 4(4):292-6. PubMed ID: 20852369
[Abstract] [Full Text] [Related]
7. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
Fu LS, Chi CS.
Acta Paediatr Taiwan; 2000 Oct 27; 41(2):80-4. PubMed ID: 10927944
[Abstract] [Full Text] [Related]
8. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
Sümegi V, Haszon I, Iványi B, Bereczki C, Papp F, Túri S.
Pediatr Nephrol; 2004 Dec 27; 19(12):1354-60. PubMed ID: 15517419
[Abstract] [Full Text] [Related]
9. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
Tenbrock K, Müller-Berghaus J, Fuchshuber A, Michalk D, Querfeld U.
Pediatr Nephrol; 1998 Aug 27; 12(6):459-62. PubMed ID: 9745868
[Abstract] [Full Text] [Related]
10. Evaluation of interleukin-18 in children with steroid-sensitive nephrotic syndrome before and after using levamisole.
Youssef DM, Abd Al-Atif AM, El-Khateeb SSH, Elshal AS.
Saudi J Kidney Dis Transpl; 2018 Aug 27; 29(3):591-597. PubMed ID: 29970735
[Abstract] [Full Text] [Related]
11. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.
Elmas AT, Tabel Y, Elmas ON.
Int Urol Nephrol; 2013 Aug 27; 45(4):1047-55. PubMed ID: 22826143
[Abstract] [Full Text] [Related]
12. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
Fu LS, Shien CY, Chi CS.
Nephron Clin Pract; 2004 Aug 27; 97(4):c137-41. PubMed ID: 15331936
[Abstract] [Full Text] [Related]
13. Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome.
Boyer O, Moulder JK, Grandin L, Somers MJ.
Pediatr Nephrol; 2008 Apr 27; 23(4):575-80. PubMed ID: 18204939
[Abstract] [Full Text] [Related]
14. Efficacy and safety of levamisole in childhood nephrotic syndrome: A meta-analysis.
Bhatt GC, Patel B, Das RR, Malik S, Bitzan M, Mishra NR.
Indian J Pharmacol; 2023 Apr 27; 55(1):43-52. PubMed ID: 36960520
[Abstract] [Full Text] [Related]
15. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N, Kim S, Craig J, Hodson E.
Arch Dis Child; 2016 Apr 27; 101(4):404-8. PubMed ID: 26289063
[Abstract] [Full Text] [Related]
16. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
Ksiazek J, Kryński J.
Pediatr Pol; 1995 Dec 27; 70(12):1037-42. PubMed ID: 8649943
[Abstract] [Full Text] [Related]
17. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
Bagga A, Sharma A, Srivastava RN.
Pediatr Nephrol; 1997 Aug 27; 11(4):415-7. PubMed ID: 9260236
[Abstract] [Full Text] [Related]
18. Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials.
Durkan AM, Hodson EM, Willis NS, Craig JC.
Kidney Int; 2001 May 27; 59(5):1919-27. PubMed ID: 11318964
[Abstract] [Full Text] [Related]
19. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M.
Pediatr Nephrol; 2006 Feb 27; 21(2):201-5. PubMed ID: 16222548
[Abstract] [Full Text] [Related]
20. Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome.
Kreeftmeijer-Vegter AR, Dorlo TP, Gruppen MP, de Boer A, de Vries PJ.
Br J Clin Pharmacol; 2015 Aug 27; 80(2):242-52. PubMed ID: 25677380
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
